Trade wars aren’t just for economists and politicians anymore. With proposed import tariffs making headlines again in 2025, medspa owners have a new concern on their radar: Will neuromodulators like Botox, Dysport, and Jeuveau become more expensive?
Short answer: Yes, possibly. And if you’re running a practice that depends on these injectable treatments, you’ll want to be ahead of this curve.
To help you stay informed and prepared, we’ve created a free downloadable report that outlines:
- The proposed and enacted tariff changes under Trump’s new trade strategy
- Which injectable brands are most at risk based on their country of origin
- How a 10% to 25% import tariff could impact your cost per unit
- Supply chain risks and inventory strategies
- Actionable business moves to protect your margins
Key Takeaways for Medspa Owners:
- Most injectables are imported. Botox is made in Ireland. Dysport comes from the UK. Jeuveau? South Korea. If a universal import tariff takes effect (as proposed), all are affected.
- Daxxify is made in the U.S. It might dodge tariffs completely, potentially becoming more price-competitive.
- Your costs could rise 10% to 25%. If a vial that costs you $600 jumps to $750, you need a plan to adjust pricing without losing clients.
- Now is the time to act. Stock up (wisely), diversify your injectable lineup, and prep your pricing strategy.
Download the Full Report: For a deeper look into how tariffs could reshape the economics of aesthetic injectables, download our exclusive industry report:
TARIFFS AND AESTHETIC INJECTABLES: IMPACT REPORT
Inside the Report:
- A brand-by-brand breakdown: Which products are made where, and how exposed they are to tariffs
- The ripple effects: From manufacturer costs to your treatment pricing
- Supply chain watch-outs and mitigation tactics
- A checklist of actionable steps medspas can take today to stay ahead
It’s not every day that international trade policy walks into your treatment room. But if Trump’s tariff strategy unfolds as outlined, it could change how you price and plan your injectable services. Stay ahead. Stay prepared. And let Medspa Mastery keep you in the know.
Sources:
-
Reuters News – Trump tariff announcements and pharma industry responses reuters.com
-
U.S. and UK Government Releases – Trade and manufacturing background (Allergan in Ireland; Ipsen in UK) gov.uk
-
Industry Analysis – Pharmaceutical trade war impact on prices and supply reuters.com
-
Company Statements – Product origins and pricing notices daxxify.com jeuveau.evolus.com
